Cause-Specific Excess Mortality During the COVID-19 Pandemic (2020–2021) in 12 Countries of the C-MOR Consortium
Name
44197_2024_Article_242.pdf
Size
1.5 MB
Format
Adobe PDF
Checksum (MD5)
39e783c94a06f93a1b17e31f2ce057a2
Author(s) • • • • • • • • •
Beeks, Victoria V.
Achilleos, Souzana
Quattrocchi, Annalisa
Pallari, Chryso T.
Critselis, Elena
Salameh, Pascale
Rahmanian Haghighi, Mohammad R.
Rodriguez-Llanes, Jose M.
Ambrosio, Giuseppe
Artemiou, Andreas
Date Issued
May 22, 2024
Journal
Journal of Epidemiology and Global Health
Publisher
Springer Netherlands
Citation
Beeks, V.V., Achilleos, S., Quattrocchi, A. et al. Cause-Specific Excess Mortality During the COVID-19 Pandemic (2020–2021) in 12 Countries of the C-MOR Consortium. J Epidemiol Glob Health (2024).
Version
Final published version
Abstract
This study investigated cause-specific mortality rates in 12 countries during the COVID-19 pandemic in 2020 and 2021.
Methods
We collected weekly cause-specific mortality data from respiratory disease, pneumonia, cardiovascular disease (CVD) and cancer from national vital statistic databases. We calculated excess mortality for respiratory disease (excluding COVID-19 codes), pneumonia, and CVD in 2020 and 2021 by comparing observed weekly against expected mortality based on historical data (2015–2019), accounting for seasonal trends. We used multilevel regression models to investigate the association between country-level pandemic-related variables and cause-specific mortality.
Results
Significant reductions in cumulative mortality from respiratory disease and pneumonia were observed in 2020 and/or 2021, except for Georgia, Northern Ireland, Kazakhstan, and Ukraine, which exhibited excess mortality for one or both causes. Australia, Austria, Cyprus, Georgia, and Northern Ireland experienced excess cumulative CVD mortality in 2020 and/or 2021. Australia, Austria, Brazil, Cyprus, Georgia, Northern Ireland, Scotland and Slovenia, experienced increased crude cumulative cancer mortality during 2020 and/or 2021 compared to previous years. Among pandemic-related variables, reported COVID-19 incidence was negatively associated with increased cancer mortality, excess respiratory, (2020) and pneumonia (2021) mortality, and positively associated with respiratory and CVD mortality (2021). Stringency of control measures were negatively associated with excess respiratory disease, CVD, and increased cancer mortality (2021).
Conclusions
This study provides evidence of substantial excess mortality from CVD, and notable reductions in respiratory disease and pneumonia in both years across most countries investigated. Our study also highlights the beneficial impact of stringent control measures in mitigating excess mortality from most causes in 2021.
MIT Department
McGovern Institute for Brain Research at MIT
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1007/s44197-024-00242-4